Drug Profile
Research programme: hepatic fibrosis therapeutics - Lee's Pharmaceutical
Alternative Names: ZK006Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Lee's Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatic fibrosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hepatic-fibrosis in Hong Kong
- 30 Sep 2010 Preclinical trials in Hepatic fibrosis in Hong Kong (unspecified route)